‘IMPACCT’ Panel Discussion: Value Generation, Real World Evidence & Life Cycle Management – Distilling Strategy for Innovation

Time: 8:30 am
day: Day Two


• In what stages of the drug life cycle does RWE have greatest impact?
• Establishing the right evidence generation plan that meets clinical, regulatory and commercial needs of a product:
• How to?
• Does it differ between big and small pharma?
• What’s the ROI vs. value generation?
• Driving internal collaboration for value-based evidence generation